These facts are updated till 9 Jan 2024, and are based on Volza's Export Import data India Export data of Ciprofloxacine usp, sourced from 70 countries export import shipments with names of buyers, suppliers, top decision maker's contact information like phone, email and LinkedIn profiles.
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: X05741, MFG: 12/2017, EXP: 11/2019|MEDICAMENTOS PARA USO HUMANO|2055X10X10T//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//2055X10X10T | India | Peru | 2055 | |||
2933595000 | CIPROFLOXACIN, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
3822003000 | CIPROFLOXACINO ETILENDIAMINA USP S/M|1134324|MATERIALES DE REFERENCIA CERTIFICADOS|25 MG|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG | India | Peru | 1 | |||
3822003000 | CIPROFLOXACINO ETILENDIAMINA USP S/M|1134324|MATERIALES DE REFERENCIA CERTIFICADOS|25 MG|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG | India | Peru | 1 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1134324|(1-CYCLOPROPYL-6-FLUORO-1,DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLINECARBOXYLIC ,AC | India | Peru | 1 | 60 More Columns Available | ||
3004902900 | C-FLOX-500MG, 500MG // C-FLOX // S/M|LOTE: W19501, W19502; MFG: 12/2017; EXP: 11/2019|MEDICAMENTOS PARA USO HUMANO|13136X10X10T//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//13136X10X10T | India | Peru | 13136 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 2 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|(1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)AMINO)-3-QUINOLIN|3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE) / LOT # R013T0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG 25MG|ITEM: 1134324 | India | Peru | 2 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R013T0, 25MG|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: DY1116, DY1117, DY1118, DY1203, DY1204, DY1205; MFG: 08/2019, EXP: 07/2022|MEDICAMENTOS PARA USO HUMANO|19101X10X10TAB//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//19101X10X10TAB | India | Peru | 19101 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG , USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1134324|(1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLINECARBOXYLIC,A | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|(1-CYCLOPROPYL-6-|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG)|1134324 | India | Peru | 2 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: E01062 // MFG.DT. 03.2019 - EXP.DT. 02.2021|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPTHALMIC SOLUTION USP - CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 40000 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R013T0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, 25MG|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: DY1647, DY1648, DY1649; MFG: 12/2019; EXP: 11/2022|MEDICAMENTOS PARA USO HUMANO|9558X10X10TAB//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//9558X10X10TAB | India | Peru | 9558 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: 0EB07118 // MFG.DT. 03.2020 - EXP.DT. 02.2022|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 50000 | |||
2933599000 | CIPROFLOXACINO ETILENDIAMINO USP MODELO:S/M|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYC|USO:USO LABORATORIO STANDARES DE REFERENCIA|UNIDAD|1134324 | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
3004201900 | CIPROFLOXACIN TABLETA,MIFLOXIN,S/M,|USP 500MG 10X10|LOTE: T0100|TABLETAS|FECHA DE FABRICACION: 02/2020 FECHA DE VENCIMIENTO: 01/2023 | India | Peru | 1000 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE USP S-M|CIPROFLOXACINE ETHYLENEDIAMINE ANALOG 25MG|ESTANDARD DE REFERENCIA PARA USO EN LABORATORIO|1 CYCLOPROPYL-6-FLUOROR-1-4-DIHYDRO-4-OXO-7 (2-AMINOE) |COD.1134324 , LOT. R144W0 | India | Peru | 3 | |||
3004902900 | CIPROFLOXACINO 0.3% , S-M , S-M|BATCH: 2EB01017 - MFG.DT. 01.2022 - EXP.DT. 12.2023|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3%- CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 65680 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
2933591200 | CIPROFLOXACINO ETILENDIAMINO A , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6- | India | Peru | 2 | |||
29419030 | CIPROFLOXACIN >> CIPROFLOXACIN HYDROCHLORIDE CIPROFLOXACIN HYDROCHLORIDE USP | India | Peru | 1500 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS C-FLOX 500MG TABLETS CIPROFLOXACIN TABLETS USP 500MG EACH TAB CONT.CIPROFLOXACINUSP EQ.TO.CIPROFLOXACIN 500MG [10X10T P | India | Peru | 40000 | |||
30042033 | CIPROFLOXACIN >> C-FLOX-500 CIPROFLOXACIN TAB.USP 500MG , EACH FILM COATED TAB.CONT. CIRPROFLOXACIN USP EQ.TO AS PER DOCUMENT QTY 10000X10X10T | India | Peru | 10000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG ; USP 500 | India | Peru | 3147 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG ; USP 500 | India | Peru | 3147 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG 10X10`S ; USP 500 | India | Peru | 3096 | |||
30049099 | TABLETS >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG 10X10`S ; USP 500 | India | Peru | 3148 | |||
30049099 | TABLETS >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP | India | Peru | 6294 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 312 PACKS: CIPROFLOXACIN OPHTHALMIC SOLUTION USP. PKG:5 ML BOTTLE CIPROFLOXACINE- IN CAPSUL TBLTS FORM ETC ; SOLU TION ; CIPROFLOXACI NE- | India | Peru | 155050 | |||
30042019 | TABLETS >> CIPROFLOXACIN TABLETS PHARMACEUTICAL DRUGS AND MEDICINES - CIPROFLOXACIN TABLETS USP 500MG. MIFLOXIN 10 X 10 IN ALU - ALU. ; CI PROFLOXACIN ; MIFLOXIN 10 | India | Peru | 4000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 100 PACKS : CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACKING: 5 ML BOTTLE. CIPROFLOXACINE- IN CAPSUL TBLTS FORM ETC ; SOL UTION ; BOTTLE. CIPROFLO XACINE- | India | Peru | 50000 | |||
30042019 | TABLETS >> CIPROFLOXACIN TABLETS Pharmaceutical Drugs & Medicine : Ciprofloxacin Tablets USP 500mg. MIFLOXIN 10X10 in Alu-Alu. ; Ciprof loxacin ; 10X 10 | India | Peru | 5000 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION USP 0.2% W/V 1 | India | Peru | 156768 | |||
30042013 | CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACK SIZE: 5 ML BOTTLE | India | Peru | 20500 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, USP, S/M | 01 VIAL DE 25 MG. | ESTANDARES DE REFERENCIA | CATALOG NUMBER: 1134324 | (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLI,NECARBOXYLIC | India | Peru | 1 | |||
2933595000 | STANDARD DE REFERENCIA USP MODELO:S/M | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG) (1-CYCLOPROPYL-6-) | CIPROFLOXACINO ETILENDIAMINO (25MG) | COMERCIALIZADO EN FRASCO | 1134324 | India | Peru | 1 | |||
3822009000 | ESTANDARES DE CALIBRACION, USP, S/M|((2-AMINOETHYL)AMINO)-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE, LOT# R013T0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, 25MG (1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 2 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG , USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER 1134324|(1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLINECARBOXYLIC,A | India | Peru | 1 | |||
3822009000 | ESTANDARES DE CALIBRACION, USP, S/M|((2-AMINOETHYL)AMINO)-3-QUINOLINEC ARBOXYLIC ACID HYDROCHLORIDE)|LOT# R013TO, ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, 25MG (1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822003000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 1 | |||
2933595000 | CIPROFLOXACINO ETILENDIAMINA ANALOGO 25 MG, USP S/M|POLVO SECO|REACTIVO PATRON DE REFERENCIA PARA ANALISIS QUIMICO DE MATERIA PRIMA|1134324 CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|CIPROFLOXACINO ETILENDIAMINA ANALOGO 25 MG | India | Peru | 1 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: T04789, T04790, T07125, T05571, T05572, T05573; MFG: 04/2016, 05/2016|MEDICAMENTOS PARA USO HUMANO|30000X10X10T//TABLETAS//EXP: 03/2018, 04/2018|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//30000X10X10T | India | Peru | 30000 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: T04792, T04793, T05569, T05571, T05572; MFG: 04/2016, 05/2016|MEDICAMENTOS PARA USO HUMANO|41384X10X10T//TABLETAS//EXP: 03/2018, 04/2018|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//41384X10X10T | India | Peru | 41384 | |||
2933499000 | CIPROFLOXACINO ETILENODIAMINO, USP, S/M|EST-NDAR PRIMARIO|PARA ANALISIS EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG)|LOTE: R013T0 // 01 UNID X 25MG,1134324 | India | Peru | 2 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: T12596, T15977, MFG: 06/2016, 10/2016, EXP: 05/2018, 09/2018|MEDICAMENTOS PARA USO HUMANO|7226X10X10T//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//7226X10X10T | India | Peru | 7226 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6- | India | Peru | 2 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6- | India | Peru | 2 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE USP S-M|CIPROFLOXACINE ETHYLENEDIAMINE ANALOG 25MG|ESTANDARD DE REFERENCIA PARA USO EN LABORATORIO|1 CYCLOPROPYL-6-FLUOROR-1-4-DIHYDRO-4-OXO-7 (2-AMINOE) |COD.1134324 , LOT. R144W0 | India | Peru | 3 | |||
2933499000 | CIPROFLOXACINO ETILENODIAMINO AN-LOGO , USP , S-M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|PRESENTACION:2 VIALES X 25 MG , CODIGO DEL PRODUCTO:1134324 LOTE:R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- | India | Peru | 2 | |||
2933499000 | CIPROFLOXACINO ETILENODIAMINO AN-LOGO , USP , S-M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|PRESENTACION:2 VIALES X 25 MG , CODIGO DEL PRODUCTO:1134324 LOTE:R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- | India | Peru | 2 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION USP 0.2% W/V 1 | India | Peru | 165000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0. | India | Peru | 65680 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ANALOGO DE CIPROFLOXACINA ETILENDIAMINA , USP , S-M|COMPUESTO ORGANICO|ESTANDAR DE REFERENCIA PARA ANALISIS|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[|SERIE: 1134324 - FRASCO X 25 MG - LT: R144W0 | India | Peru | 3 | |||
3822009000 | ANALOGO DE CIPROFLOXACINA ETILENDIAMINA , USP , S-M|COMPUESTO ORGANICO|ESTANDAR DE REFERENCIA PARA ANALISIS|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[|SERIE: 1134324 - FRASCO X 25 MG - LT: R144W0 | India | Peru | 3 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S-M|-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE) , 25 MG|LOT NUM: R144W0, ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S-M|-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE) , 25 MG|LOT NUM: R144W0, ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004201900 | CIPROFLOXACINO , MIFLOXIN , S-M|BATCH N¦ T1108|MFG DATE 04-2021 - EXP DATE 03-2024|CIPROFLOXACIN TABLETS USP 500MG | India | Peru | 5000 | |||
3004201900 | CIPROFLOXACINO , MIFLOXIN , S-M|BATCH N¦ T1108|MFG DATE 04-2021 - EXP DATE 03-2024|CIPROFLOXACIN TABLETS USP 500MG | India | Peru | 5000 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- ( (2-AMIN|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- ( (2-AMIN|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 1 | |||
3822009000 | CIPROFLOXACINO ETILENDIAMINO , USP , S-M|CIPROFLOXACINO ETILENDIAMINO|ESTANDAR DE REFERENCIA PARA ANALISIS EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|1134324 | India | Peru | 1 | |||
3822009000 | CIPROFLOXACINO ETILENDIAMINO , USP , S-M|CIPROFLOXACINO ETILENDIAMINO|ESTANDAR DE REFERENCIA PARA ANALISIS EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|1134324 | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|QUINOLINECARBOXYLIC ACID HYDROCHLRIDE) - LOT #R 144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[ (2-AMINO 3822009000 HS Code | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|QUINOLINECARBOXYLIC ACID HYDROCHLRIDE) - LOT #R 144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[ (2-AMINO 3822009000 HS Code | India | Peru | 1 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION USP 0.2% W-V 100 ML PLASTIC BOTTLE CIPRONOR ; 1 00 | India | Peru | 323621 | |||
48192090 | TABLETS >> CIPROFLOXACIN TABLETS MonoCTN of MIFLOXIN 500 Ciprofloxacin Tablets USP 500mg. ; Ciprofloxa cin | India | Peru | 50 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S-M|LINECARBOXYLIC ACID HYDROCHLORIDE) , 25MG|ITEM NUMBER: 1134324, LOT# R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (I-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- ( (2-AMINO|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LINECARBOXYLIC ACID HYDROCHLORIDE), 25MG|ITEM NUMBER: 1134324, LOT# R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (I-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINO|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: 0EB11270 // MFG.DT. 06.2020 - EXP.DT. 05.2022 | BATCH: 0EB13359 // MFG.DT. 08.2018|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|SE ACOGE A LA SEGUNDA DISPOSICION TRANSITORIA DS. NO. 016-2011-SA - LEY NO.29459,CIPROFLO | India | Peru | 60000 | |||
3004902900 | CIPROFLOXACINO 0.3% , S-M , S-M|BATCH: 0EB11270 - MFG.DT. 06.2020 - EXP.DT. 05.2022 | BATCH: 0EB13359 - MFG.DT. 08.2018|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|SE ACOGE A LA SEGUNDA DISPOSICION TRANSITORIA DS. NO. 016-2011-SA - LEY NO.29459 , CIPROFLO | India | Peru | 60000 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: 0EB07118, 0EB09264, 0EB10268, 0EB11270 // MFG.DT. 03.2020; 06.2020 - EXP.DT. 02.202|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 132800 | |||
3822003000 | ESTANDAR PRIMARIO USP,USP,1134324,|PARA ANALISIS EN LABORATORIO FARMACEUTICO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) | India | Peru | 1 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 120 PACKS:CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACKING :5 ML BOTTLE CIPROFLOX ACINE- IN CAPSUL TBLTS FORM ETC ; SOLUT ION | India | Peru | 60000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 266 PACKS:CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACKING :5 ML BOTTLE CIPROFLOX ACINE- IN CAPSUL TBLTS FORM ETC ; SOLUT ION | India | Peru | 132800 | |||
2933499000 | CIPROFLOXACIN, USP, SIN MODELO|R013T0/EAR99|ESTANDAR DE REFERENCIA|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG)|PARA USO MEDICO | India | Peru | 1 | |||
2933499000 | CIPROFLOXACIN , USP , SIN MODELO|R013T0-EAR99|ESTANDAR DE REFERENCIA|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG) |PARA USO MEDICO | India | Peru | 1 | |||
2933599000 | CIPROFLOXACINO ETILENDIAMINO USP MODELO:S-M|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYC|USO:USO LABORATORIO STANDARES DE REFERENCIA|UNIDAD|1134324 | India | Peru | 1 | |||
3004201900 | CIPROFLOXACIN TABLETA , MIFLOXIN , S-M , |USP 500MG 10X10|NRO DE LOTE: T0100|TABLETAS RECUBIERTAS|FECHA DE FABRICACION: 02-2020 FECHA DE VENCIMIENTO: 01-2023 | India | Peru | 4000 | |||
3004201900 | CIPROFLOXACIN TABLETA,MIFLOXIN,S/M,|USP 500MG 10X10|NRO DE LOTE: T0100|TABLETAS RECUBIERTAS|FECHA DE FABRICACION: 02/2020 FECHA DE VENCIMIENTO: 01/2023 | India | Peru | 4000 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R013T0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 |
HSN Code | Product Description | Origin | Destination | Qty. | Importer | Exporter |
---|
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: X05741, MFG: 12/2017, EXP: 11/2019|MEDICAMENTOS PARA USO HUMANO|2055X10X10T//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//2055X10X10T | India | Peru | 2055 | |||
2933595000 | CIPROFLOXACIN, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
3822003000 | CIPROFLOXACINO ETILENDIAMINA USP S/M|1134324|MATERIALES DE REFERENCIA CERTIFICADOS|25 MG|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG | India | Peru | 1 | |||
3822003000 | CIPROFLOXACINO ETILENDIAMINA USP S/M|1134324|MATERIALES DE REFERENCIA CERTIFICADOS|25 MG|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG | India | Peru | 1 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1134324|(1-CYCLOPROPYL-6-FLUORO-1,DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLINECARBOXYLIC ,AC | India | Peru | 1 | 60 More Columns Available | ||
3004902900 | C-FLOX-500MG, 500MG // C-FLOX // S/M|LOTE: W19501, W19502; MFG: 12/2017; EXP: 11/2019|MEDICAMENTOS PARA USO HUMANO|13136X10X10T//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//13136X10X10T | India | Peru | 13136 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 2 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|(1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)AMINO)-3-QUINOLIN|3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE) / LOT # R013T0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG 25MG|ITEM: 1134324 | India | Peru | 2 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R013T0, 25MG|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: DY1116, DY1117, DY1118, DY1203, DY1204, DY1205; MFG: 08/2019, EXP: 07/2022|MEDICAMENTOS PARA USO HUMANO|19101X10X10TAB//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//19101X10X10TAB | India | Peru | 19101 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG , USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER : 1134324|(1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLINECARBOXYLIC,A | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|(1-CYCLOPROPYL-6-|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG)|1134324 | India | Peru | 2 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: E01062 // MFG.DT. 03.2019 - EXP.DT. 02.2021|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPTHALMIC SOLUTION USP - CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 40000 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R013T0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, 25MG|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: DY1647, DY1648, DY1649; MFG: 12/2019; EXP: 11/2022|MEDICAMENTOS PARA USO HUMANO|9558X10X10TAB//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//9558X10X10TAB | India | Peru | 9558 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: 0EB07118 // MFG.DT. 03.2020 - EXP.DT. 02.2022|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 50000 | |||
2933599000 | CIPROFLOXACINO ETILENDIAMINO USP MODELO:S/M|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYC|USO:USO LABORATORIO STANDARES DE REFERENCIA|UNIDAD|1134324 | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
3004201900 | CIPROFLOXACIN TABLETA,MIFLOXIN,S/M,|USP 500MG 10X10|LOTE: T0100|TABLETAS|FECHA DE FABRICACION: 02/2020 FECHA DE VENCIMIENTO: 01/2023 | India | Peru | 1000 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 3 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE USP S-M|CIPROFLOXACINE ETHYLENEDIAMINE ANALOG 25MG|ESTANDARD DE REFERENCIA PARA USO EN LABORATORIO|1 CYCLOPROPYL-6-FLUOROR-1-4-DIHYDRO-4-OXO-7 (2-AMINOE) |COD.1134324 , LOT. R144W0 | India | Peru | 3 | |||
3004902900 | CIPROFLOXACINO 0.3% , S-M , S-M|BATCH: 2EB01017 - MFG.DT. 01.2022 - EXP.DT. 12.2023|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0.3%- CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 65680 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
2933591200 | CIPROFLOXACINO ETILENDIAMINO A , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6- | India | Peru | 2 | |||
29419030 | CIPROFLOXACIN >> CIPROFLOXACIN HYDROCHLORIDE CIPROFLOXACIN HYDROCHLORIDE USP | India | Peru | 1500 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS C-FLOX 500MG TABLETS CIPROFLOXACIN TABLETS USP 500MG EACH TAB CONT.CIPROFLOXACINUSP EQ.TO.CIPROFLOXACIN 500MG [10X10T P | India | Peru | 40000 | |||
30042033 | CIPROFLOXACIN >> C-FLOX-500 CIPROFLOXACIN TAB.USP 500MG , EACH FILM COATED TAB.CONT. CIRPROFLOXACIN USP EQ.TO AS PER DOCUMENT QTY 10000X10X10T | India | Peru | 10000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG ; USP 500 | India | Peru | 3147 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG ; USP 500 | India | Peru | 3147 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG 10X10`S ; USP 500 | India | Peru | 3096 | |||
30049099 | TABLETS >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP500 MG 10X10`S ; USP 500 | India | Peru | 3148 | |||
30049099 | TABLETS >> CIPROFLOXACIN TABLETS TAB.CIPRONOR CIPROFLOXACIN TABLETS USP | India | Peru | 6294 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 312 PACKS: CIPROFLOXACIN OPHTHALMIC SOLUTION USP. PKG:5 ML BOTTLE CIPROFLOXACINE- IN CAPSUL TBLTS FORM ETC ; SOLU TION ; CIPROFLOXACI NE- | India | Peru | 155050 | |||
30042019 | TABLETS >> CIPROFLOXACIN TABLETS PHARMACEUTICAL DRUGS AND MEDICINES - CIPROFLOXACIN TABLETS USP 500MG. MIFLOXIN 10 X 10 IN ALU - ALU. ; CI PROFLOXACIN ; MIFLOXIN 10 | India | Peru | 4000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 100 PACKS : CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACKING: 5 ML BOTTLE. CIPROFLOXACINE- IN CAPSUL TBLTS FORM ETC ; SOL UTION ; BOTTLE. CIPROFLO XACINE- | India | Peru | 50000 | |||
30042019 | TABLETS >> CIPROFLOXACIN TABLETS Pharmaceutical Drugs & Medicine : Ciprofloxacin Tablets USP 500mg. MIFLOXIN 10X10 in Alu-Alu. ; Ciprof loxacin ; 10X 10 | India | Peru | 5000 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION USP 0.2% W/V 1 | India | Peru | 156768 | |||
30042013 | CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACK SIZE: 5 ML BOTTLE | India | Peru | 20500 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, USP, S/M | 01 VIAL DE 25 MG. | ESTANDARES DE REFERENCIA | CATALOG NUMBER: 1134324 | (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLI,NECARBOXYLIC | India | Peru | 1 | |||
2933595000 | STANDARD DE REFERENCIA USP MODELO:S/M | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG) (1-CYCLOPROPYL-6-) | CIPROFLOXACINO ETILENDIAMINO (25MG) | COMERCIALIZADO EN FRASCO | 1134324 | India | Peru | 1 | |||
3822009000 | ESTANDARES DE CALIBRACION, USP, S/M|((2-AMINOETHYL)AMINO)-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE, LOT# R013T0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, 25MG (1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 2 | |||
2933599000 | CIPROFLOXACIN ETHYLENEDIAMINE ANALOG , USP, S/M|01 VIAL DE 25 MG|ESTANDARES DE REFERENCIA|CATALOG NUMBER 1134324|(1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINOETHYL)-AMINO)-3-QUINOLINECARBOXYLIC,A | India | Peru | 1 | |||
3822009000 | ESTANDARES DE CALIBRACION, USP, S/M|((2-AMINOETHYL)AMINO)-3-QUINOLINEC ARBOXYLIC ACID HYDROCHLORIDE)|LOT# R013TO, ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG, 25MG (1-CYCLOPROPYL-6-FLUORO-1, 4-DIHYDRO-4-OXO-7-|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822003000 | CIPROFLOXACIN ETHYLENEDIAMINE, USP, S/M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 1 | |||
2933595000 | CIPROFLOXACINO ETILENDIAMINA ANALOGO 25 MG, USP S/M|POLVO SECO|REACTIVO PATRON DE REFERENCIA PARA ANALISIS QUIMICO DE MATERIA PRIMA|1134324 CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|CIPROFLOXACINO ETILENDIAMINA ANALOGO 25 MG | India | Peru | 1 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: T04789, T04790, T07125, T05571, T05572, T05573; MFG: 04/2016, 05/2016|MEDICAMENTOS PARA USO HUMANO|30000X10X10T//TABLETAS//EXP: 03/2018, 04/2018|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//30000X10X10T | India | Peru | 30000 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: T04792, T04793, T05569, T05571, T05572; MFG: 04/2016, 05/2016|MEDICAMENTOS PARA USO HUMANO|41384X10X10T//TABLETAS//EXP: 03/2018, 04/2018|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//41384X10X10T | India | Peru | 41384 | |||
2933499000 | CIPROFLOXACINO ETILENODIAMINO, USP, S/M|EST-NDAR PRIMARIO|PARA ANALISIS EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG)|LOTE: R013T0 // 01 UNID X 25MG,1134324 | India | Peru | 2 | |||
3004902900 | C-FLOX-500, 500MG // C-FLOX // S/M|LOTE: T12596, T15977, MFG: 06/2016, 10/2016, EXP: 05/2018, 09/2018|MEDICAMENTOS PARA USO HUMANO|7226X10X10T//TABLETAS|C-FLOX-500, 500MG // CIPROFLOXACIN TABLETS USP 500MG//7226X10X10T | India | Peru | 7226 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6- | India | Peru | 2 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6- | India | Peru | 2 | |||
2933591200 | CIPROFLOXACIN ETHYLENEDIAMINE USP S-M|CIPROFLOXACINE ETHYLENEDIAMINE ANALOG 25MG|ESTANDARD DE REFERENCIA PARA USO EN LABORATORIO|1 CYCLOPROPYL-6-FLUOROR-1-4-DIHYDRO-4-OXO-7 (2-AMINOE) |COD.1134324 , LOT. R144W0 | India | Peru | 3 | |||
2933499000 | CIPROFLOXACINO ETILENODIAMINO AN-LOGO , USP , S-M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|PRESENTACION:2 VIALES X 25 MG , CODIGO DEL PRODUCTO:1134324 LOTE:R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- | India | Peru | 2 | |||
2933499000 | CIPROFLOXACINO ETILENODIAMINO AN-LOGO , USP , S-M|ESTANDARES PRIMARIOS PARA ANALISIS EN LABORATORIO|PRESENTACION:2 VIALES X 25 MG , CODIGO DEL PRODUCTO:1134324 LOTE:R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- | India | Peru | 2 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822900000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION USP 0.2% W/V 1 | India | Peru | 165000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC CIPROFLOXACIN OPHTHALMIC SOLUTION USP 0. | India | Peru | 65680 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ANALOGO DE CIPROFLOXACINA ETILENDIAMINA , USP , S-M|COMPUESTO ORGANICO|ESTANDAR DE REFERENCIA PARA ANALISIS|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[|SERIE: 1134324 - FRASCO X 25 MG - LT: R144W0 | India | Peru | 3 | |||
3822009000 | ANALOGO DE CIPROFLOXACINA ETILENDIAMINA , USP , S-M|COMPUESTO ORGANICO|ESTANDAR DE REFERENCIA PARA ANALISIS|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[|SERIE: 1134324 - FRASCO X 25 MG - LT: R144W0 | India | Peru | 3 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S-M|-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE) , 25 MG|LOT NUM: R144W0, ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S-M|-3-QUINOLINECARBOXYLIC ACID HYDROCHLORIDE) , 25 MG|LOT NUM: R144W0, ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- (|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004201900 | CIPROFLOXACINO , MIFLOXIN , S-M|BATCH N¦ T1108|MFG DATE 04-2021 - EXP DATE 03-2024|CIPROFLOXACIN TABLETS USP 500MG | India | Peru | 5000 | |||
3004201900 | CIPROFLOXACINO , MIFLOXIN , S-M|BATCH N¦ T1108|MFG DATE 04-2021 - EXP DATE 03-2024|CIPROFLOXACIN TABLETS USP 500MG | India | Peru | 5000 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- ( (2-AMIN|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|LOT NUM: R144W0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7- ( (2-AMIN|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 1 | |||
2933595000 | CIPROFLOXACIN ETHYLENEDIAMINE , USP , S-M|ESTANDAR DE REFERENCIA CERTIFICADO PARA USO EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYCLOPROPYL-6-|1134324 | India | Peru | 1 | |||
3822009000 | CIPROFLOXACINO ETILENDIAMINO , USP , S-M|CIPROFLOXACINO ETILENDIAMINO|ESTANDAR DE REFERENCIA PARA ANALISIS EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|1134324 | India | Peru | 1 | |||
3822009000 | CIPROFLOXACINO ETILENDIAMINO , USP , S-M|CIPROFLOXACINO ETILENDIAMINO|ESTANDAR DE REFERENCIA PARA ANALISIS EN LABORATORIO|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|1134324 | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|QUINOLINECARBOXYLIC ACID HYDROCHLRIDE) - LOT #R 144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[ (2-AMINO 3822009000 HS Code | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA , USP , S-M|QUINOLINECARBOXYLIC ACID HYDROCHLRIDE) - LOT #R 144W0|ITEM: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (1-CYCLOPROPYL-6-FLUORO-1 , 4-DIHYDRO-4-OXO-7-[ (2-AMINO 3822009000 HS Code | India | Peru | 1 | |||
30042033 | CIPROFLOXACIN >> CIPROFLOXACIN INJECTION CIPROFLOXACIN INJECTION USP 0.2% W-V 100 ML PLASTIC BOTTLE CIPRONOR ; 1 00 | India | Peru | 323621 | |||
48192090 | TABLETS >> CIPROFLOXACIN TABLETS MonoCTN of MIFLOXIN 500 Ciprofloxacin Tablets USP 500mg. ; Ciprofloxa cin | India | Peru | 50 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S-M|LINECARBOXYLIC ACID HYDROCHLORIDE) , 25MG|ITEM NUMBER: 1134324, LOT# R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (I-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7- ( (2-AMINO|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LINECARBOXYLIC ACID HYDROCHLORIDE), 25MG|ITEM NUMBER: 1134324, LOT# R144W0|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (I-CYCLOPROPYL-6-FLUORO-1,4-DIHYDRO-4-OXO-7-((2-AMINO|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: 0EB11270 // MFG.DT. 06.2020 - EXP.DT. 05.2022 | BATCH: 0EB13359 // MFG.DT. 08.2018|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|SE ACOGE A LA SEGUNDA DISPOSICION TRANSITORIA DS. NO. 016-2011-SA - LEY NO.29459,CIPROFLO | India | Peru | 60000 | |||
3004902900 | CIPROFLOXACINO 0.3% , S-M , S-M|BATCH: 0EB11270 - MFG.DT. 06.2020 - EXP.DT. 05.2022 | BATCH: 0EB13359 - MFG.DT. 08.2018|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|SE ACOGE A LA SEGUNDA DISPOSICION TRANSITORIA DS. NO. 016-2011-SA - LEY NO.29459 , CIPROFLO | India | Peru | 60000 | |||
3004902900 | CIPROFLOXACINO 0.3%, S/M, S/M|BATCH: 0EB07118, 0EB09264, 0EB10268, 0EB11270 // MFG.DT. 03.2020; 06.2020 - EXP.DT. 02.202|MEDICAMENTO DE USO HUMANO|CIPROFLOXACIN OPHTHALMIC SOLUTION USP - CIPROFLOXACINO|CIPROFLOXACINO 0.3% SOLUCION OFTALMICA | India | Peru | 132800 | |||
3822003000 | ESTANDAR PRIMARIO USP,USP,1134324,|PARA ANALISIS EN LABORATORIO FARMACEUTICO|1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) | India | Peru | 1 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 120 PACKS:CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACKING :5 ML BOTTLE CIPROFLOX ACINE- IN CAPSUL TBLTS FORM ETC ; SOLUT ION | India | Peru | 60000 | |||
30042013 | CIPROFLOXACIN >> CIPROFLOXACIN OPHTHALMIC 266 PACKS:CIPROFLOXACIN OPHTHALMIC SOLUTION USP PACKING :5 ML BOTTLE CIPROFLOX ACINE- IN CAPSUL TBLTS FORM ETC ; SOLUT ION | India | Peru | 132800 | |||
2933499000 | CIPROFLOXACIN, USP, SIN MODELO|R013T0/EAR99|ESTANDAR DE REFERENCIA|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG)|PARA USO MEDICO | India | Peru | 1 | |||
2933499000 | CIPROFLOXACIN , USP , SIN MODELO|R013T0-EAR99|ESTANDAR DE REFERENCIA|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25MG) |PARA USO MEDICO | India | Peru | 1 | |||
2933599000 | CIPROFLOXACINO ETILENDIAMINO USP MODELO:S-M|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG (25 MG) (1-CYC|USO:USO LABORATORIO STANDARES DE REFERENCIA|UNIDAD|1134324 | India | Peru | 1 | |||
3004201900 | CIPROFLOXACIN TABLETA , MIFLOXIN , S-M , |USP 500MG 10X10|NRO DE LOTE: T0100|TABLETAS RECUBIERTAS|FECHA DE FABRICACION: 02-2020 FECHA DE VENCIMIENTO: 01-2023 | India | Peru | 4000 | |||
3004201900 | CIPROFLOXACIN TABLETA,MIFLOXIN,S/M,|USP 500MG 10X10|NRO DE LOTE: T0100|TABLETAS RECUBIERTAS|FECHA DE FABRICACION: 02/2020 FECHA DE VENCIMIENTO: 01/2023 | India | Peru | 4000 | |||
3822009000 | ESTANDARES DE REFERENCIA, USP, S/M|LOT# R013T0|ITEM NUMBER: 1134324|CIPROFLOXACIN ETHYLENEDIAMINE ANALOG|REACTIVO PARA PRUEBA DE LABORATORIO | India | Peru | 1 |
Volza's data of India Ciprofloxacine usp exports allows you to study detailed data with buyer supplier names for last 10 years.
Volza's data of India Ciprofloxacine usp exports helps you create a export strategy from detailed trade data with buyer supplier names, price, volume for last 10 years.
You can find India Ciprofloxacine usp export market intelligence of last 10 years with buyer, supplier, price and volume from volza.com
You can find New markets for Ciprofloxacine usp exports from Volza Country wise market report of last 10 years with growth rate, buyer, supplier, price and volume.
Top 5 HSN codes for Ciprofloxacine usp are HSN Code 3004902900 , HSN Code 3822009000 , HSN Code 2933599000, HSN Code 2933595000, HSN Code 2933591200, You can check for details at https://www.volza.com/hs-codes.
Volza's data of India Ciprofloxacine usp exports to Peru is 100% authentic as it is based on actual export import shipments and is collected globally from over 20,000 ports from over 70+ Countries.
Data of India Ciprofloxacine usp exports to Peru contains strategic information and is very useful for exporters and importers who want to expand global trade, improve supply chain of Ciprofloxacine usp, find economical vendors, new buyers and fast growing markets.
Data of India Ciprofloxacine usp exports to Peru contains date of shipment, Name and contact details of exporter, importer, product description, price, quantity, country & port of origin, country & port of destination and many other fields.
We update information of India Ciprofloxacine usp exports to Peru every month.
As per the Volza's India export data of Ciprofloxacine usp, Peru accounted for maximum share with 334 shipments.
India wide 334 of Ciprofloxacine usp shipments were exported to Peru.
You can download latest data of Jan-2024 of India Ciprofloxacine usp exports to Peru here
You can download Volza India Ciprofloxacine usp export data with names of buyers and suppliers.
There are two options to Subscribe, Online Access starts at $1500 and reports from Volza Consulting starts at $1000.
Volza Sales team will be happy to answer your questions, you can reach us at [email protected] or +1-302 786 5213.
Online |
---|
Mode Do it yourself |
Availiblity Instant access |
Cost Access 209+ countries data |
Payment Instant Online |
Data Format Excel |
View More |
Volza Consulting |
---|
Mode Customer Order |
Availiblity Starts within 48 hours |
Cost $1000 |
Payment Online and other modes |
Data Format Excel, SQL, MSAcess & Custom |
View More |
Support
Important Links
Partners
Trade Data
About Us
Partners